These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 31824482)
1. T Regulatory Cells From Non-obese Diabetic Mice Show Low Responsiveness to IL-2 Stimulation and Exhibit Differential Expression of Anergy-Related and Ubiquitination Factors. Godoy GJ; Olivera C; Paira DA; Salazar FC; Ana Y; Stempin CC; Motrich RD; Rivero VE Front Immunol; 2019; 10():2665. PubMed ID: 31824482 [TBL] [Abstract][Full Text] [Related]
2. Differences in T regulatory cells between mouse strains frequently used in immunological research: Treg cell quantities and subpopulations in NOD, B6 and BALB/c mice. Godoy GJ; Paira DA; Olivera C; Breser ML; Sanchez LR; Motrich RD; Rivero VE Immunol Lett; 2020 Jul; 223():17-25. PubMed ID: 32330480 [TBL] [Abstract][Full Text] [Related]
4. Defects in IL-2R signaling contribute to diminished maintenance of FOXP3 expression in CD4(+)CD25(+) regulatory T-cells of type 1 diabetic subjects. Long SA; Cerosaletti K; Bollyky PL; Tatum M; Shilling H; Zhang S; Zhang ZY; Pihoker C; Sanda S; Greenbaum C; Buckner JH Diabetes; 2010 Feb; 59(2):407-15. PubMed ID: 19875613 [TBL] [Abstract][Full Text] [Related]
5. High Thymic Output of Effector CD4 Zhao Y; Alard P; Kosiewicz MM J Immunol Res; 2019; 2019():8785263. PubMed ID: 31281853 [TBL] [Abstract][Full Text] [Related]
6. Reduced IL-2 expression in NOD mice leads to a temporal increase in CD62Llo FoxP3+ CD4+ T cells with limited suppressor activity. Goudy KS; Johnson MC; Garland A; Li C; Samulski RJ; Wang B; Tisch R Eur J Immunol; 2011 May; 41(5):1480-1490. PubMed ID: 21469091 [TBL] [Abstract][Full Text] [Related]
7. Interaction of TNF with TNF receptor type 2 promotes expansion and function of mouse CD4+CD25+ T regulatory cells. Chen X; Bäumel M; Männel DN; Howard OM; Oppenheim JJ J Immunol; 2007 Jul; 179(1):154-61. PubMed ID: 17579033 [TBL] [Abstract][Full Text] [Related]
8. IL-1 beta breaks tolerance through expansion of CD25+ effector T cells. O'Sullivan BJ; Thomas HE; Pai S; Santamaria P; Iwakura Y; Steptoe RJ; Kay TW; Thomas R J Immunol; 2006 Jun; 176(12):7278-87. PubMed ID: 16751371 [TBL] [Abstract][Full Text] [Related]
9. Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. Itoh M; Takahashi T; Sakaguchi N; Kuniyasu Y; Shimizu J; Otsuka F; Sakaguchi S J Immunol; 1999 May; 162(9):5317-26. PubMed ID: 10228007 [TBL] [Abstract][Full Text] [Related]
10. Th3 cells in peripheral tolerance. I. Induction of Foxp3-positive regulatory T cells by Th3 cells derived from TGF-beta T cell-transgenic mice. Carrier Y; Yuan J; Kuchroo VK; Weiner HL J Immunol; 2007 Jan; 178(1):179-85. PubMed ID: 17182553 [TBL] [Abstract][Full Text] [Related]
11. Interleukin-2 signaling and the maintenance of self-tolerance. Nelson BH Curr Dir Autoimmun; 2002; 5():92-112. PubMed ID: 11826762 [TBL] [Abstract][Full Text] [Related]
12. Dysregulation of anergy-related factors involved in regulatory T cells defects in Systemic Lupus Erythematosus patients: Rapamycin and Vitamin D efficacy in restoring regulatory T cells. Banica LM; Besliu AN; Pistol GC; Stavaru C; Vlad V; Predeteanu D; Ionescu R; Stefanescu M; Matache C Int J Rheum Dis; 2016 Dec; 19(12):1294-1303. PubMed ID: 25351606 [TBL] [Abstract][Full Text] [Related]
13. Diabetes in non-obese diabetic mice is not associated with quantitative changes in CD4+ CD25+ Foxp3+ regulatory T cells. Mellanby RJ; Thomas D; Phillips JM; Cooke A Immunology; 2007 May; 121(1):15-28. PubMed ID: 17428252 [TBL] [Abstract][Full Text] [Related]
15. Defective activation of protein kinase C and Ras-ERK pathways limits IL-2 production and proliferation by CD4+CD25+ regulatory T cells. Hickman SP; Yang J; Thomas RM; Wells AD; Turka LA J Immunol; 2006 Aug; 177(4):2186-94. PubMed ID: 16887978 [TBL] [Abstract][Full Text] [Related]
16. Defective thymic T cell activation by concanavalin A and anti-CD3 in autoimmune nonobese diabetic mice. Evidence for thymic T cell anergy that correlates with the onset of insulitis. Zipris D; Lazarus AH; Crow AR; Hadzija M; Delovitch TL J Immunol; 1991 Jun; 146(11):3763-71. PubMed ID: 1827815 [TBL] [Abstract][Full Text] [Related]
17. B7-1 and B7-2 differentially control peripheral homeostasis of CD4(+)CD25(+)Foxp3(+) regulatory T cells. Zeng M; Guinet E; Nouri-Shirazi M Transpl Immunol; 2009 Jan; 20(3):171-9. PubMed ID: 18848987 [TBL] [Abstract][Full Text] [Related]
18. CD28 co-stimulation restores T cell responsiveness in NOD mice by overcoming deficiencies in Rac-1/p38 mitogen-activated protein kinase signaling and IL-2 and IL-4 gene transcription. Zhang J; Salojin KV; Delovitch TL Int Immunol; 2001 Mar; 13(3):377-84. PubMed ID: 11222507 [TBL] [Abstract][Full Text] [Related]
19. Strong impact of CD4+ Foxp3+ regulatory T cells and limited effect of T cell-derived IL-10 on pathogen clearance during Plasmodium yoelii infection. Abel S; Lückheide N; Westendorf AM; Geffers R; Roers A; Müller W; Sparwasser T; Matuschewski K; Buer J; Hansen W J Immunol; 2012 Jun; 188(11):5467-77. PubMed ID: 22544931 [TBL] [Abstract][Full Text] [Related]
20. Altered homeostasis and development of regulatory T cell subsets represent an IL-2R-dependent risk for diabetes in NOD mice. Dwyer CJ; Bayer AL; Fotino C; Yu L; Cabello-Kindelan C; Ward NC; Toomer KH; Chen Z; Malek TR Sci Signal; 2017 Dec; 10(510):. PubMed ID: 29259102 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]